162 related articles for article (PubMed ID: 32547653)
1. Importance of pleural findings in patients with amyloid cardiomyopathy complicated with refractory pleural effusion.
Noda H; Nitta M; Taguchi Y; Matsumoto K; Sugano T; Ishigami T; Ishikawa T; Tamura K; Kimura K
J Cardiol Cases; 2020 Jun; 21(6):205-208. PubMed ID: 32547653
[TBL] [Abstract][Full Text] [Related]
2. Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis.
Berk JL; Keane J; Seldin DC; Sanchorawala V; Koyama J; Dember LM; Falk RH
Chest; 2003 Sep; 124(3):969-77. PubMed ID: 12970025
[TBL] [Abstract][Full Text] [Related]
3. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
Tomberli B; Cappelli F; Perfetto F; Olivotto I
JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
[TBL] [Abstract][Full Text] [Related]
4. [Echocardiographic findings of a patient with cardiac amyloidosis and left ventricular outflow obstruction].
Noma S; Akaishi M; Murayama A; Akiyama H; Ogawa S; Handa S; Nakamura Y; Sohma Y; Hosoda Y; Gotoh M
J Cardiogr; 1982 Mar; 12(1):267-78. PubMed ID: 6889625
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
[TBL] [Abstract][Full Text] [Related]
6. [A case of systemic primary amyloidosis with BHL and M-protein in pleural effusion].
Tsuchiya Y; Shimokata K; Sasou H; Ichikawa M
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 May; 31(5):624-8. PubMed ID: 8331850
[TBL] [Abstract][Full Text] [Related]
7. Amyloidosis - a rare cause of refractory heart failure in a young female.
Costache II; Costea CF; Danciu M; Costan VV; Aursulesei V; Dumitrescu GF; Turliuc MD; Sava A
Rom J Morphol Embryol; 2017; 58(1):201-206. PubMed ID: 28523319
[TBL] [Abstract][Full Text] [Related]
8. A case of cardiac amyloidosis with diuretic-refractory pleural effusions treated with bevacizumab.
Bae SH; Hwang JY; Kim WJ; Yoon HH; Kim JM; Nam YH; Baek HG; Cho YR; Park SY; Kim JH; Kim SH; Park TH; Lee GN; Rha SH; Kim YD
Korean Circ J; 2010 Dec; 40(12):671-6. PubMed ID: 21267391
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic approach to cardiac amyloidosis.
Amin HZ; Mori S; Sasaki N; Hirata K
Kobe J Med Sci; 2014 Jun; 60(1):E5-E11. PubMed ID: 25011639
[TBL] [Abstract][Full Text] [Related]
10. Amyloid Light-Chain Amyloidosis Manifesting as Heart Failure with Preserved Ejection Fraction in a Patient with Hyper-Immunoglobulin E-emia.
Nojima Y; Ihara M; Kurimoto T; Nanto S
Am J Case Rep; 2016 Apr; 17():235-40. PubMed ID: 27064109
[TBL] [Abstract][Full Text] [Related]
11. [Late gadolinium enhancement and T1 mapping for the diagnosis of cardiac amyloidosis].
Cui Q; Yu J; Shen W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Dec; 31(12):1538-1541. PubMed ID: 32029045
[TBL] [Abstract][Full Text] [Related]
12. Amyloidosis and cardiac involvement.
Cacoub P; Axler O; De Zuttere D; Hausfater P; Amoura Z; Walter S; Wechsler B; Godeau P; Piette JC
Ann Med Interne (Paris); 2000 Dec; 151(8):611-7. PubMed ID: 11173703
[TBL] [Abstract][Full Text] [Related]
13. Cardiac changes in systemic amyloidosis: visualisation by magnetic resonance imaging.
Cheng AS; Banning AP; Mitchell AR; Neubauer S; Selvanayagam JB
Int J Cardiol; 2006 Oct; 113(1):E21-3. PubMed ID: 17049635
[TBL] [Abstract][Full Text] [Related]
14. Echocardiographic findings in nine patients with cardiac amyloidosis: their correlation with necropsy findings.
Nishikawa H; Nishiyama S; Nishimura S; Kondo K; Imai S; Kato K; Nakanishi S; Seki A; Yamakado T; Isaka N
J Cardiol; 1988 Mar; 18(1):121-33. PubMed ID: 3221306
[TBL] [Abstract][Full Text] [Related]
15. Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report.
Miyagawa S; Miyamoto T; Sato Y
Eur Heart J Case Rep; 2020 Jun; 4(3):1-7. PubMed ID: 32617472
[TBL] [Abstract][Full Text] [Related]
16. Successful management of refractory pleural effusion due to systemic immunoglobulin light chain amyloidosis by vincristine adriamycin dexamethasone chemotherapy: a case report.
Araoka T; Takeoka H; Nishioka K; Ikeda M; Kondo M; Hoshina A; Kishi S; Araki M; Mimura R; Murakami T; Mima A; Nagai K; Abe H; Doi T
J Med Case Rep; 2010 Oct; 4():322. PubMed ID: 20955545
[TBL] [Abstract][Full Text] [Related]
17. M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.
Siqueira-Filho AG; Cunha CL; Tajik AJ; Seward JB; Schattenberg TT; Giuliani ER
Circulation; 1981 Jan; 63(1):188-96. PubMed ID: 7438392
[TBL] [Abstract][Full Text] [Related]
18. Giant Eustachian valve and left ventricular systolic dysfunction in a patient with non-dilated amyloid cardiomyopathy.
Arora S; Kadiyala M; Moore L
Eur J Echocardiogr; 2008 Jan; 9(1):145-7. PubMed ID: 17600767
[TBL] [Abstract][Full Text] [Related]
19. Amyloid Cardiomyopathy in the Emergency Department.
Baca M; Newberry M
J Emerg Med; 2019 Feb; 56(2):205-209. PubMed ID: 30553561
[TBL] [Abstract][Full Text] [Related]
20. Pleural effusions in systemic amyloidosis.
Berk JL
Curr Opin Pulm Med; 2005 Jul; 11(4):324-8. PubMed ID: 15928500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
